Methuen, MA, United States of America

Kristian Eric Teichert

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Rubius Therapeutics, Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kristian Eric Teichert. Retrieved from https://idiyas.com/inventor/kristian-eric-teichert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kristian Eric Teichert: Innovator in Functionalized Erythroid Cells

Introduction

Kristian Eric Teichert is a notable inventor based in Methuen, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of functionalized erythroid cells. His work has implications for both human pharmaceutical and veterinary applications.

Latest Patents

Teichert holds a patent for "Functionalized erythroid cells." This patent describes novel preparations of functionalized erythroid cells and related compositions, reagents, and methods for use in various applications. He has 1 patent to his name, showcasing his innovative approach to biotechnology.

Career Highlights

Kristian is currently associated with Rubius Therapeutics, Inc., where he continues to advance his research and development efforts. His work at the company focuses on harnessing the potential of erythroid cells for therapeutic purposes.

Collaborations

Throughout his career, Teichert has collaborated with talented individuals such as Tom Wickham and Tiffany F Chen. These collaborations have contributed to the advancement of his research and the successful development of innovative solutions in the field.

Conclusion

Kristian Eric Teichert is a pioneering inventor whose work on functionalized erythroid cells is paving the way for new therapeutic applications. His contributions to biotechnology are noteworthy and continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…